inactivated rabies vaccine (Imovax) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now
The rabies vaccine is a vaccine used to prevent rabies. There are several rabies vaccines available that are both safe and effective. Vaccinations must be administered prior to rabies virus exposure or within the latent period after exposure to prevent the disease. Transmission of rabies virus to humans typically occurs through a bite or scratch from an infectious animal, but exposure can occur through indirect contact with the saliva from an infectious individual.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

cell-culture rabies vaccine | human diploid cell rabies vaccine | human diploid cell vaccine rabies vaccine | human rabies vaccine | imovax | inactivated rabies virus | inactivated rabies virus vaccine | meruvax ii | rabipur | rubella virus vaccine, live attenuated, strain ra 27/3 (human diploid fibroblast) | verocell rabies vaccine | verorab | vero rabies vaccine

Organizations (52)

Research & Development (51)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (24)

Approved Indications (1)


 

Rabies (approved 1979)

Experimental Indications - Clinical Trial Phases 1-4 (24)


 

Communicable Diseases (Phase 3)

COVID-19 (Phase 4)

Dengue (Phase 2)

Dengue Virus (Phase 2)

Disease Transmission, Infectious (Phase 1/Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Dysentery, Bacillary (Phase 1/Phase 2)

Encephalitis, Japanese (Phase 3)

Healthy Volunteers (Phase 3)

Immunization (Phase 1/Phase 2)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Mononegavirales Infections (Phase 3)

Neoplasms (Phase 1)

Only Child (Phase 3)

Primary Immunodeficiency Diseases (Phase 4)

Rabies (Phase 4)

Rabies virus (Phase 2)

Rhabdoviridae Infections (Phase 3)

RNA Virus Infections (Phase 3)

Severe Dengue (Phase 2)

Vaccines (Phase 3)

Virus Diseases (Phase 4)

Zoonoses (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 56
  • # of Trial Organizations: 51

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue